🇺🇸 FDA
Pipeline program

Ibutamoren Mesylate, Ibutamoren Mesylate, Matched placebo capsules administered orally once per day, Ibutamoren Mesylate

LUM-201-10

Phase 3 small_molecule active

Quick answer

Ibutamoren Mesylate, Ibutamoren Mesylate, Matched placebo capsules administered orally once per day, Ibutamoren Mesylate for Growth Hormone Deficiency (GHD) is a Phase 3 program (small_molecule) at Pharma Mar S.A. with 1 ClinicalTrials.gov record(s).

Program details

Company
Pharma Mar S.A.
Indication
Growth Hormone Deficiency (GHD)
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials